This result indicated that the methylation of KLRB1 was a most pronounced decrease in Liver hepatocellular carcinoma (LIHC), Colon adenocarcinoma (COAD), and Prostate adenocarcinoma (PRAD) (Figure 1F). The gene discussed is KLRB1; the disease is colon adenocarcinoma.